Homepage  /  News

Workshop on IUI, Infertility Workup, Patient Selection for ART and Sperm DNA Fragmentation Testing

Saif Ur Rehman - Project Director

ORGANS Life Sciences - Lahore Institute of Fertility & Endocrinology

08 January 2012

| | | |

ORGANS Life Sciences is fastly emerging ART/IVF Company in Middle East, having strong business representation with world leading companies in ART like, Gynemed Germany, InVitroCare USA, KitaZato Japan, Reproline.

LIFE, Lahore Institute of Fertility & Endocrinology, is one of the leading IVF Center in Pakistan, having 1st PGD Lab in Pakistan, and facilitating doctors and patients from Middle East every year.

Lecture - 1: Infertility Workup, Management and Patient Selection for ART - By Prof. Muhammad Tayyab, Senior IVF Consultant at Lahore Institute of Fertility & Endocrinology

Lecture - 2: Practicalities of IUI - Improving Success - By Dr. Haroon Latif Khan, Chief Embryologist and PGD Scientist at Lahore Institute of Fertility & Endocrinology

Lecture - 3: Sperm DNA Fragmentation Testing - Significance in IUI - By Mr. Saif Ur Rehman, Project Director, Galaxy IVF (UK) Limited / Mr. Talha Mabood Paracha - Senior Embryologist Galaxy IVF

Lecture - 4: Hands on Session on Sperm Washing Techniques and Insemination using Dummy Pelvis

DATE & TIMINGS: 27th January 2012 (Friday) from 9 am to 4 pm (Tea & Lunch Inclusive)


ORGANS Life Sciences

Level-41, Emirates Towers

Sheikh Zayed Road

Dubai, UAE

Ph: +971 4 313 2879



Only 10 Participants shall be allowed. You can send your CV at to be reviewed by the trainers. Upon acceptance you will receive Registration Confirmation alongwith payment instructions.

Share IVF News on FaceBook   Share IVF News on Google+   Share IVF News on Twitter


Page Views: 3969
Add to Favorites | Reply to Ad | Tell Your Friends
Date Added: 08 January 2012   Date Updated: 08 January 2012
Customer Reviews (0)
write a review
(No reviews found. You may write the first one!)

Join Our Newsletter - Don't Miss Anything!!!

Stay in touch with the latest news by subscribing to our regular email newsletters